IP, going once, going twice, sold!

Credit: GETTY IMAGES" /> Credit: GETTY IMAGES The eBay of intellectual property will launch this April, allowing Fortune 500 companies and mom-and-pop organizations to buy and sell technology patents both on the auction floor and online. The first large-scale, live intellectual property (IP) auction, initiated by Chicago-based merchant bank Ocean Tomo, will take place April 5-6 at the Ritz Carlton San Francisco and will be simulcast online. While only 15% of IP will be in the life sc

Written byIshani Ganguli
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The eBay of intellectual property will launch this April, allowing Fortune 500 companies and mom-and-pop organizations to buy and sell technology patents both on the auction floor and online. The first large-scale, live intellectual property (IP) auction, initiated by Chicago-based merchant bank Ocean Tomo, will take place April 5-6 at the Ritz Carlton San Francisco and will be simulcast online. While only 15% of IP will be in the life sciences this time around, the second of the planned biannual auctions, to be held in October in New York City, will focus on biotechnology.

"It's something I'm really excited about," says Ronald J. Riley, president of Professional Inventors Alliance, a Washington, DC-based advocacy group. Riley described the current system as labor intensive and marked by inefficiencies. "The auction creates great potential for exposing the patent to all the players at once," he says.

The idea of an open marketplace for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies